|
|
|
|
 |
Congressional
Testimony
|
|
 |
|
|
|
|
|
|
|
- December 2007 - No Testimonies
- November 14, 2007
Norris E. Alderson, Ph.D.
Director, Office of Science and Health Coordination
Subject: "Dental Mercury"
Before: Committee on Oversight and Government Reform, Subcommittee on Domestic Policy House of Representatives
- November 13, 2007
David Acheson, M.D., F.R.C.P.
Assistant Commissioner for Food Protection
Subject: "Food Safety"
Before: Committe on Energy and Commerce,
Subcommittee on Oversight and Investigations
- November 1, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: " FDA's Foreign Drug Inspection Program"
Before: Committe on Energy and Commerce,
Subcommittee on Oversight and Investigations
- October 11, 2007
David W. K. Acheson, M.D.,
Assistant Commissioner for Food Protection
Subject: " FDA's Imported Foods"
Before: Committe on Energy and Commerce,
Subcommittee on Oversight and Investigations
- October 4, 2007
Steven M. Solomon, D.V.M., M.P.H.,
Deputy Director of the Office of Regional Operations
Subject: "Import Safety"
Before: Comittee on Ways and Means, Subcommittee on Trade
- October 3, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: "H.R. 1108, Family Smoking Prevention and Tobacco Control Act."
Before: Committee on Energy and Commerce,
Subcommittee on Health
- September 26, 2007
Randall Lutter, Ph.D.
Deputy Commissioner for Policy
Subject: "Regulation of Imported FDA-Regulated Products"
Before: Committee on Energy and Commerce,
Subcommittee on Health
- September 25, 2007
David Acheson, M.D., F.R.C.P.
Assistant Commissioner for Food Protection
Subject: "Food Safety and Food Imports from China"
Before: Committee on Energy and Commerce,
Subcommittee on Health
- August 2007 - No Testimonies
- July 24, 2007
David Acheson, M.D., F.R.C.P.
Assistant Commissioner for Food Protection
Subject: "Federal
Efforts to Mitigate Vulnerabilities in the Food Supply Chain"
Before: Subcommittee on Emerging Threats,
Cybersecurity, and Science and Technology
- July 18, 2007
Murray M. Lumpkin, M.D.
Deputy Commissioner for International and Special Program
Subject: "Safety of Chinese Imports: Oversight and Analysis of the Federal Response"
Before: Committee on Commerce, Science, and Tranportation
- July 17, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: "Alzheimer's Disease: FDA's Role In New Product Development"
Before: Subcommittee on Retirement and Aging,
Committee on Health, Education, Labor and Pensions
- July 17, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: "Diminished Capacity: Can the FDA Assure the Safety and Security of the Nation's Food Supply"
Before: Subcommittee on Oversight and Investigations,
Committee on Energy and Commerce
- June 26, 2007
John K. Jenkins, M.D.
Director, Office of New Drugs
Subject: "Erythropoiesis-Stimulating Agents (ESA)"
Before: Committee on Ways and Means, Subcommittee on Health
- June 12, 2007
Randall W. Lutter, Ph.D.
Acting Deputy Commissioner for Policy
Subject: "Legislative Hearing"
Before: Subcommittee on Health,
Committee on Energy and Commerce
- June 6, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: "Avandia"
Before: Committee on Oversight and Government Reform
- June 1, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: "Critical Path Initiative"
Before: Subcommittee on Agriculture, Rural Development
- May 22, 2007
Rear Admiral Sandra Kweder, M.D.,
Deputy Director of the Office of New Drugs, U.S. Food and Drug Administration
Subject: "Programs Affecting Safety and Innovation in Pediatric Therapies "
Before:Subcommittee on Health,
Committee on Energy and Commerce
- May 16, 2007
Jeffrey E. Shuren, M.D., J.D.
Assistant Commissioner for Policy, U.S. Food and Drug Administration
Subject: " Medical Device User Fee and Modernization Act "
Before: Subcommittee on Health,
Committee on Energy and Commerce
- May 15, 2007
David Acheson, M.D., F.R.C.P.
Assistant Commissioner for Food Protection , U.S. Food and Drug Administration
Subject: "FDA Food Produce "
Before: Committee on Agriculture,
Subcommittee on Horticulture and Organic Agriculture
- May 9, 2007
Steven Galson, M.D., M.P.H.
Director, Center for Drug Evaluation and Research U.S. Food and Drug Administration
Subject: "Modernizing Drug Safety "
Before: Subcommittee on Health,
Committee on Energy and Commerce
- May 9, 2007
David Acheson, M.D., F.R.C.P.
Assistant Commissioner for Food Protection, U.S. Food and Drug Administration
Subject: "Food Safety and Animal Health - Melamine "
Before: Committee on Agriculture
- May 2, 2007
Janet Woodcock, M.D.
Deputy Commissioner, Chief Medical Officer,
Food and Drug Administration
Subject: "Assessing the Impact of a Safe and Equitable Biosimilar Policy in the United States"
Before: Subcommittee on Health,
Committee
on Energy and Commerce
- May 1, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: " FDA Overview "
Before: The Committee on Oversight and Government Reform
- April 25, 2007
Robert E. Brackett, Ph.D.
Director, Center for Food Safety and Applied Nutrition
Subject:"FDA’s Role in Measuring and Assessing Perchlorate Levels in Food and Beverages"
Before: Committee on Energy and Commerce,
Subcommittee on Environment and
Hazardous Materials
- April 19, 2007
Steven K. Galson, M.D., M.P.H.
Director, Center for Drug Evaluation and Research
Subject:"Bio-Identical Hormones: Sound Science or Bad Medicine"
Before: Senate Special committee on Aging
- April 18, 2007
Jesse L. Goodman, M.D., M.P.H.
Director, Center for Biologics, Evaluation and Research.
Subject: "FDA’s Role in the Regulation of Vaccines"
Before: Subcommittee on Emerging Threats, Committee on Homeland Security
- April 17, 2007
Theresa M. Mullin, Ph.D.
Assistant Commissioner for Planning
Subject: "Prescription Drug User
Fee Act"
Before: Subcommittee on Health, Committee
on Energy and Commerce
- April 12, 2007
Stephen F. Sundlof, D.V.M., Ph.D.
Director, FDA Center for Veterinary Medicine
Subject: "Contamination
of Pet Food"
Before: Senate Agriculture, Rural Development,
and Related Agencies Appropriations Subcommittee
- March 26, 2007
Janet Woodcock, M.D.
Deputy Commissioner, Chief Medical Officer,
Food and Drug Administration
Subject: "Follow-on
Protein Products"
Before: Committee
on Oversight and Government Reform
- March 22, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: The Adequacy of FDA Efforts to Assure the Safety of the Drug Supply -- Part II
Before: Subcommittee on Oversight and Investigations,
Committee on Energy and Commerce
- March 14, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: Highlights of the Proposal for PDUFA IV
Before: Committee on Health, Education, Labor and Pensions
- March 12, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: Food Safety and the Safety of Fresh Produce
Before: The Senate Agriculture, Rural Development,
and Related Agencies Appropriations Subcommittee
- March 7, 2007
Randall W. Lutter, Ph.D.
Acting Deputy Commissioner for Policy
Subject: Policy
Implications of Importing Drugs into the United States
Before:
Committee on Commerce, Science, and Transportation
- February 27, 2007
Andrew C. von Eschenbach, M.D.
Commissioner of the Food and Drug Administration
Subject: President’s Fiscal Year 2008 Budget Request for FDA
Before: The Senate Agriculture, Rural Development,
and Related Agencies Appropriations Subcommittee
- January - No Testimonies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
